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How Good is ‘Good Outcome’ Schizophrenia 
in Long-term in Developing countries. 
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Introduction:  
• The illness of schizophrenia has always been a 
matter of concern for its nature and extent of 
outcome particularly for its regional and cultural 
differences. 
•   The concept of outcome has been evolving and this 
study examines the scenario of good outcome in 
developing countries. 
• Methods Re-examination of recovered patients in 
ten years long term, naturalistic, prospective study 
using Meltzer et al’s 13 outcome criteria & on a new 
outcome scale 
Methods 
In a Longitudinal , Naturalistic,  
cohort study, patients with 
completed 10 years treatment were 
assessed on clinical and social 
parameter. 
These patients were re-assessed for 
the status and quality of recovery 
using Global outcome scale  on 7 
outcome criteria 
Results were analyzed.  
Screening  : 
 Patients diagnosed 
DSM IIIR : First 
Hospitalization 
Recruited Assessment 
Follow up for ten 
years Reassessment  
Clinical 
Social Outcome 
( Global outcome 
criteria.)  
Methods 
Present 
study 
Good 
outcome : 
67 
1996 
Phase I 
N=200 
Follow up period for 
10 years 
Phase II 
Drop outs : 93 
2003 
Phase III 
N= 107 
    Study parameters: 
•  Demography 
•  Clinical parameters 
•  Global Outcome criteria 
•  PANSS 
•  CGIS 
Multiple outcome criteria in schizophrenia 
Various parameter quantified based on clinical outcome and using popular 
scales for measurement 
Thirteen criteria 
• 1.Psychopathology (positive 
symptoms, negative symptoms 
and disorganization) 
• 2.Cognitive function (attention, 
executive function, working 
memory, recall memory, 
semantic memory, storage 
memory) 
• 3.Interpersonal social function 
• 4.Work–school function  
• 5.Extra pyramidal function 
(parkinsonism, akathesia, 
tardive dyskinesia) 
Meltzer HY. Eur Psychiatry 1995;10(Suppl. 1):19S–25S 
6.Independent living 
7.Aggression 
8.Quality of life 
9.Compliance 
10.Hospitalization 
11.Family burden 
12.Social burden 
13.Suicidality 

Psychopathology: Total 
Positive Symptoms 
P<0.001 
The residual features and persisting symptoms include positive 
symptoms, negative symptoms, suicidality, side effects like EPS, 
Interpersonal Social Functioning 
NS 
Cognition: Global  
Work/ employment 
EPS 
Independent Living 
Aggression 
Quality of Life  
Hospitalization 
Family Burden 
Suicidality 
Global assessment of functioning 
Hospitalization does not Correlate with any of the thirteen  
outcome variables ( P < 0.01 to P< 0.5, NS) 
parameters  Hospitalized(25)  Non‐hospitalized (42)  P‐value  signiﬁcance 
Posi:ve symptoms  28  42  0.01  NS 
Nega:ve symptoms  15  21  0.05  NS 
Disorganiza:on  17  24  0.05  NS 
Interpersonal 
func:oning 
12  30  0.01  NS 
Cogni:on not Declined  14  20  0.05  NS 
Independent living 
possible  
12  17  0.5  NS 
Aggression not present  22  30  0.05  NS 
Improved QOL  16  30  0.5  NS 
Family Burden  15  25  0.01  NS 
Social burden  23  29  0.05  NS 
No Suicidality  23  29  0.01  NS 
Sustained work/school  15  17  0.01  NS 
Cross analysis of independent variables against hospitalized Vs non-
hospitalized did not provide statistically significant parameter. The two 
groups do not differ significantly on several parameters assessed. 
Improvement with various Criterias 
Re-assessed outcome at 10 years 
Good outcome appears to have several variables 
Why does schizophrenia show ‘poor’ 
outcome in developing Countries as well. 
• Changing culture 
• Treatment response 
• Changing phenomenology: Needs studies 
• Changing families 
• Late intervention 
• Treatment design, Lack of continuity 
• Lack of support system, resource, accessibility 
• Stigma 
• Poor advocacy and awareness 
Conclusion  
Schizophrenia is a 
complex 
neurobehavioral 
disorder with limited 
outcome.  
Multidimensional 
Clinical and Social 
recovery is achieved in 
32% subjects in ten 
years treatment. 
Half of the patients 
improve with no 
concomitant difficulty 
while another half 
improves varieties of 
disability 
Outcome measures in 
schizophrenia need to be re-
structured to capture real-life 
situation.  
